Approval · Notice of Compliance 8709 · 2007
ALDARA: Notice of Compliance 8709
Issued April 16, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8709
- Date
- April 16, 2007
- Company
- Graceway PharmaceuticalsLondon, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Immune response modifier
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALDARA | 02239505 | Marketed |
Medicinal ingredients
- IMIQUIMOD 50 MG per G